All Type of News
1 of 4 medicines approved this year was OTC drug
3 of 4 medicines approved this year were ETC drugs, and the rest was OTC drugs.
According to the Ministry of Food and Drug Safety(MFDS), there were the total 1,427 drug products approved between January and August, a...
‘Prevision Medicine Project Group’ to provide medical services personalized for insurable cancer patients
The ‘Precision Medicine Project Group’ will be established to adopt a personalized treatment system for incurable cancer patients.
In order to implement the personalized medical services and have a new future growth ...
Nongshim-affiliated Newteranex acquires Namshin Pharm to enter drug distribution market
Newteranex, a subsidiary of Nongshim, acquired employees and business rights of Namshin Pharm(CEO Joon-Ho Lee) to enter the pharmaceutical distribution market.
Using the acquisition of the company as an opportunity, ...
Gilead-Yuhan’s co-promotion agreement for Sovaldi and Harvoni
Gilead Sciences Korea(CEO Seung-Woo Lee) and Yuhan Corporation(CEO Jung-Hee Lee) announced a co-promotion ceremony of ‘Sovaldi’ and ‘Harvoni,’ chronic hepatitis C treatments, on the 31st of August.
The co-promotion a...
Viread leads outpatient prescription market last July, chased by Lipitor
While Gilead Sciences’ Viread was rushing at the top in the outpatient prescription market last July, Lipitor was chasing after it. Among the top 15 medicines, in addition, Chong Kun Dang’s Gliatilin and Daewoong Bio’...
Listed pharmas’ personnel expense/sales ratio at 14.7%
Listed pharmaceutical companies reportedly had a personnel expense/sales ratio approximately at 15% on average.
There were only 7 companies which recorded less than 10% in the ratio: Kwang Dong Pharmaceutical, Hwail,...
Which are 6 pharmas exposed for rebate case related to hospital located Cheonan?
Seoul Metropolitan Police Agency’s Intellectual Crime Investigation Team announced on the 31st that it indicted 11 medical representatives from 6 pharmaceutical companies and 4 people including a director of hospital ...
Huons signs MOU agreement to export KRW 100 billion products of ‘Hutox’ to other countriesHuons(CEO Gi-An Eom) announced the company signed a strategic memorandum of understanding(MOU) to supply KRW 100 billion products of ‘Hutox,’ its botulinum toxin product, with i...
|
Will opening a pharmacy inside of hospital be possible?
The Administrative Trial Committee’s decision that it would be available to open a pharmacy inside of Gyeongsang National University Hospital located in Gyeongnam has angered the pharmacists’ society.
Allowing to ope...
Binex, Pharmacell and Aprogen record highest merchandise sales increase rate in order
The KOSDAQ listed pharmaceutical companies’ increase rate of merchandise sales from the last year to this year was higher than the one of KOSPI listed pharmaceutical companies. When it came to the percentage of mercha...
